Chemed Corp (CHE): Price and Financial Metrics

Chemed Corp (CHE): $476.47

-10.13 (-2.08%)

POWR Rating

Component Grades














  • CHE scores best on the Quality dimension, with a Quality rank ahead of 97.78% of US stocks.
  • CHE's strongest trending metric is Value; it's been moving up over the last 197 days.
  • CHE ranks lowest in Growth; there it ranks in the 20th percentile.

CHE Stock Summary

  • Of note is the ratio of Chemed Corp's sales and general administrative expense to its total operating expenses; 98.54% of US stocks have a lower such ratio.
  • With a year-over-year growth in debt of -51.95%, Chemed Corp's debt growth rate surpasses just 6.92% of about US stocks.
  • The volatility of Chemed Corp's share price is greater than that of merely 4.19% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Chemed Corp are JOBS, SSTK, HAE, EBS, and TTEK.
  • Visit CHE's SEC page to see the company's official filings. To visit the company's web site, go to

CHE Stock Price Chart Interactive Chart >

Price chart for CHE

CHE Price/Volume Stats

Current price $476.47 52-week high $560.00
Prev. close $486.60 52-week low $417.41
Day low $473.05 Volume 93,800
Day high $482.58 Avg. volume 96,488
50-day MA $459.99 Dividend yield 0.28%
200-day MA $489.58 Market Cap 7.60B

Chemed Corp (CHE) Company Bio

Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The company offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. It also provides plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is based in Cincinnati, Ohio.

CHE Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$476.47$657.36 38%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Chemed Corp. To summarize, we found that Chemed Corp ranked in the 63th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. As for the metrics that stood out in our discounted cash flow analysis of Chemed Corp, consider:

  • Interest coverage, a measure of earnings relative to interest payments, is 169.15; that's higher than 96.44% of US stocks in the Healthcare sector that have positive free cash flow.
  • The business' balance sheet suggests that 0% of the company's capital is sourced from debt; this is greater than just 5.04% of the free cash flow producing stocks we're observing.
  • CHE's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 56.5% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

ENDP, HCSG, MCK, DVA, and OMI can be thought of as valuation peers to CHE, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.

CHE Latest News Stream

Event/Time News Detail
Loading, please wait...

CHE Latest Social Stream

Loading social stream, please wait...

View Full CHE Social Stream

Latest CHE News From Around the Web

Below are the latest news stories about Chemed Corp that investors may wish to consider to help them evaluate CHE as an investment opportunity.

Chemed Corporation to Present at the BofA Securities 2021 Virtual Health Care Conference

Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021, at 12:30 PM (ET).

Yahoo | May 4, 2021

Chemed's (CHE) CEO Kevin McNamara on Q1 2021 Results - Earnings Call Transcript

Chemed Corporation (CHE) Q1 2021 Earnings Conference Call March 28, 2021 10:30 AM ET Company Participants Sherri Warner – Investor Relations Kevin McNamara – President and Chief Executive Officer Dave Williams – Executive Vice President and Chief Financial Officer Nick Westfall – President and Chief Executive Officer-Chemed's VITAS Healthcare Corporation...

SA Transcripts on Seeking Alpha | April 29, 2021

Chemed (CHE) Q1 Earnings Beat Estimates, Gross Margin Up

Chemed's (CHE) first-quarter 2021 revenues increase year-over-year on solid growth across its Roto-Rooter arm.

Yahoo | April 28, 2021

Chemed Corp. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / April 28, 2021 / Chemed Corp. (NYSE:CHE) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on April 28, 2021 at 10:00 AM Eastern Time.

Yahoo | April 28, 2021

Chemed (CHE) Q1 Earnings and Revenues Beat Estimates

Chemed (CHE) delivered earnings and revenue surprises of 5.71% and 2.01%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | April 27, 2021

Read More 'CHE' Stories Here

CHE Price Returns

1-mo 2.90%
3-mo -6.42%
6-mo -3.56%
1-year 13.76%
3-year 52.73%
5-year 276.04%
YTD -10.47%
2020 21.59%
2019 55.58%
2018 17.01%
2017 52.32%
2016 7.89%

CHE Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CHE Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8837 seconds.